These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1919160)
1. Augmentation of mouse natural killer cell activity by combined hyperthermia and streptococcal preparation, OK-432 (Picibanil) treatment. Taradi M; Urano M; Taradi SK; Maruyama Y Int J Hyperthermia; 1991; 7(4):653-65. PubMed ID: 1919160 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of the thermal response of murine tumour and normal tissues by a streptococcal preparation, OK-432 (Picibanil). Urano M; Taradi M; Taradi SK Int J Hyperthermia; 1991; 7(1):113-23. PubMed ID: 2051067 [TBL] [Abstract][Full Text] [Related]
3. Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines. Nanjo M; Moriya Y; Hashimoto S; Kataoka M; Saito M; Yoshida T; Ishida N Int J Immunopharmacol; 1991; 13(2-3):205-15. PubMed ID: 1906439 [TBL] [Abstract][Full Text] [Related]
4. Effect of thermoimmunotherapy with OK-432 on the development of spontaneous lung metastases in mice. Taradi SK; Taradi M; Urano M Int J Hyperthermia; 1992; 8(2):221-6. PubMed ID: 1573311 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum. Urano M; Yamashita T; Suit HD; Gerweck LE Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. Oshimi K; Kano S; Takaku F; Okumura K J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124 [TBL] [Abstract][Full Text] [Related]
7. Thermal enhancement of the effect of ifosfamide against a spontaneous murine fibrosarcoma, FSa-II. Kuroda M; Urano M; Reynolds R Int J Hyperthermia; 1997; 13(1):125-31. PubMed ID: 9024933 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4. Ahmed SU; Okamoto M; Oshikawa T; Tano T; Sasai A; Kan S; Hiroshima T; Ohue H; Moriya Y; Ryoma Y; Saito M; Sato M J Immunother; 2004; 27(6):432-41. PubMed ID: 15534487 [TBL] [Abstract][Full Text] [Related]
9. Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors. Fujioka T; Ishikura K; Tanji S; Okamoto T; Koike H; Aoki H; Ohhori T; Kubo T Int J Immunopharmacol; 1990; 12(4):419-26. PubMed ID: 2391188 [TBL] [Abstract][Full Text] [Related]
10. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice]. Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190 [TBL] [Abstract][Full Text] [Related]
11. Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus. Harada Y; Kurokawa E; Endo H; Kimura T; Saito M; Sugawara Y; Irie H; Ito K; Fujii M; Shimizu Y Microbiol Immunol; 1989; 33(6):467-77. PubMed ID: 2549347 [TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice. Saito M; Nanjo M; Kataoka M; Moriya Y; Sugawara Y; Yoshida T; Ishida N Cancer Res; 1988 Aug; 48(15):4163-7. PubMed ID: 3390809 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells. Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069 [TBL] [Abstract][Full Text] [Related]
14. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice. Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841 [TBL] [Abstract][Full Text] [Related]
15. Augmentation by OK-432 of generation of culture-induced killer cells. Ujiie T Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231 [TBL] [Abstract][Full Text] [Related]
16. The effect of radiation therapy combined with natural killer cells against spontaneous murine fibrosarcoma. Nakagawa K; Yoshida F; Omori N; Tsunoda T; Nose T Biotherapy; 1990; 2(1):69-75. PubMed ID: 2205258 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells. Bonavida B; Katz J; Hoshino T Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275 [TBL] [Abstract][Full Text] [Related]
18. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation. Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968 [TBL] [Abstract][Full Text] [Related]
19. In vitro augmentation of natural killing activity by OK-432. Uchida A; Micksche M Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467 [TBL] [Abstract][Full Text] [Related]
20. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)]. Mukai M; Ando K; Koike S Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]